ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 15 of 42 for:    Microcephaly

Metabolic Study of Cockayne Syndrome (METABO-CS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03044210
Recruitment Status : Recruiting
First Posted : February 6, 2017
Last Update Posted : October 4, 2017
Sponsor:
Information provided by (Responsible Party):
University Hospital, Strasbourg, France

Brief Summary:

Cockayne syndrome (CS) is related to defective DNA transcription and/or repair and belongs to the family of Nucleotide Excision Repair. It is an autosomal recessive multisystemic disorder characterized by mental retardation, microcephaly, severe growth failure with lipoatrophia, sensorial impairment, cutaneous photosensitivity, dental decay, enophtalmios. The disease is progressive causing severe impairments but there's currently no therapeutics for the disease.

Growth failure, feeding difficulties and lipoatrophia are prognostic keys of CS but physiopathology is unknown.

According to preliminary assays, our goal is to test the hypothesis that cachexia is due to hypometabolism. We also want to test the potential link between this basal metabolism modification and mitochondrial dysfunction and somatotrope axis, and correlation between the basal metabolism degree and global severity of the disease.


Condition or disease Intervention/treatment Phase
Cockayne Syndrome Other: Metabolic evaluation Not Applicable

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 45 participants
Allocation: Non-Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Basic Science
Official Title: Metabolic Study of Cockayne Syndrome
Actual Study Start Date : April 4, 2017
Estimated Primary Completion Date : April 2019
Estimated Study Completion Date : April 2019

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Cockayne patients

Interventions performed:

  • blood sample
  • urinary collection
  • metabolic evaluation
  • clinical evaluation
Other: Metabolic evaluation
  • diet assessment
  • biological evaluation
  • clinical evaluation
  • metabolic evaluation (calorimetry)

Control subjects

Interventions performed:

  • urinary collection
  • metabolic evaluation
  • clinical evaluation
Other: Metabolic evaluation
  • diet assessment
  • biological evaluation
  • clinical evaluation
  • metabolic evaluation (calorimetry)




Primary Outcome Measures :
  1. Rest energetic cost measured by indirect calorimetry compared to calculated Black equation [ Time Frame: Day 0 ]

Secondary Outcome Measures :
  1. Rest energetic cost measured by indirect calorimetry compared to calculated theorical equations [ Time Frame: Day 0 ]
  2. Hormonal axis evaluation and mitochondrial activity measured by level of hormones and lactates/pyruvates in blood [ Time Frame: Day 0 ]
  3. Respiratory quotient measured by indirect calorimetry [ Time Frame: Day 0 ]
  4. Fat mass and lean mass measured by impedancemetry [ Time Frame: Day 0 ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   6 Months and older   (Child, Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Cockayne patients:

Inclusion criteria :

  • Male and female with cockayne syndrome
  • Age>6 months

Exclusion criteria:

  • Intercurrent diseases
  • Subject in period of exclusion
  • Pregnancy and breastfeeding

Control subjects :

Inclusion criteria :

  • Sister or brother of Cockayne patients
  • Age>6 months

Exclusion criteria:

  • Intercurrent diseases
  • Subject in periods of exclusion
  • Pregnancy and breastfeeding

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03044210


Contacts
Contact: Marie-Aude SPITZ, MD 03 88 12 77 55 ext +33 marie-aude.spitz@chru-strasbourg.fr
Contact: Vincent LAUGEL, MD, PhD 0388128498 ext +33 vincent.laugel@chru-strasbourg.fr

Locations
France
Centre d'Investigation Clinique Recruiting
Strasbourg, France, 67098
Contact: Myriam DURAND    0388128736 ext +33    myriam.durand@chru-strasbourg.fr   
Principal Investigator: Marie-Aude SPITZ, MD         
Sub-Investigator: Vincent LAUGEL, MD, PhD         
Sponsors and Collaborators
University Hospital, Strasbourg, France
Investigators
Principal Investigator: Marie-Aude SPITZ, MD Hôpitauc Universitaires de Strasbourg

Responsible Party: University Hospital, Strasbourg, France
ClinicalTrials.gov Identifier: NCT03044210     History of Changes
Other Study ID Numbers: 6372
First Posted: February 6, 2017    Key Record Dates
Last Update Posted: October 4, 2017
Last Verified: October 2017
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Keywords provided by University Hospital, Strasbourg, France:
Rest energetic cost measured by indirect calorimetry
Hormonal axis
Mitochondrial oxidative phosphorylation
Basal metabolism

Additional relevant MeSH terms:
Syndrome
Cockayne Syndrome
Disease
Pathologic Processes
Dwarfism
Bone Diseases, Developmental
Bone Diseases
Musculoskeletal Diseases
Heredodegenerative Disorders, Nervous System
Neurodegenerative Diseases
Nervous System Diseases
Abnormalities, Multiple
Congenital Abnormalities
Genetic Diseases, Inborn
DNA Repair-Deficiency Disorders
Metabolic Diseases